{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2016", "item": "https://www.patentleaderboard.com/2016/"}, {"@type": "ListItem", "position": 3, "name": "Amgen", "item": "https://www.patentleaderboard.com/2016/company/amgen"}, {"@type": "ListItem", "position": 4, "name": "Patrick Hoffmann", "item": "https://www.patentleaderboard.com/2016/inventor/fl:pa_ln:hoffmann-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
PH

Patrick Hoffmann — 2 Patents in 2016

AMAmgen: 2 patents #61 of 377Top 20%
BOBOE: 1 patents #555 of 1,364Top 45%
Munich, DE: #153 of 1,082 inventorsTop 15%
Overall (2016): #109,774 of 481,213Top 25%
2 Patents 2016

Issued Patents 2016

Showing 1–2 of 2 patents

Patent #TitleCo-InventorsDate
9486475 PPS for the prevention of potential adverse effects caused by CD3 specific binding domains Peter Kufer, Dirk Nagorsen, Juergen Scheele, Gerhard Zugmaier, Matthias Klinger +2 more 2016-11-08
9340621 Binding molecules for BCMA and CD3 Peter Kufer, Tobias Raum, Roman Kischel, Ralf Lutterbuese, Doris Rau +4 more 2016-05-17